Prognosis
U.K. Backs Cambridge Plan for Vaccine Against Many Coronaviruses
- Cambridge scientists received $2.5 million to develop shot
- DNA-based vaccine aims to fight multiple coronaviruses
This article is for subscribers only.
Scientists from the University of Cambridge won funding from the U.K. government to start trials for a DNA-based vaccine that aims to protect against multiple coronaviruses.
The government has invested 1.9 million pounds ($2.5 million) to develop the shot, with the researchers planning to begin phase I trials in the autumn, the university said in a statement Wednesday. The team aims to use genetic sequences of other known coronaviruses to create one vaccine that goes beyond Covid-19 to fight related diseases such as Middle East respiratory syndrome, or MERS.